Connect Biopharma GAAP EPS of -$0.31
Source: SeekingAlpha
2025-11-12 10:40:39 ET
More on Connect Biopharma
- Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript
- Seeking Alpha’s Quant Rating on Connect Biopharma
- Historical earnings data for Connect Biopharma
- Financial information for Connect Biopharma
Read the full article on Seeking Alpha
For further details see:
Connect Biopharma GAAP EPS of -$0.31
Connect Biopharma Holdings Limited
NASDAQ: CNTB
CNTB Trading
0.67% G/L:
$3 Last:
770 Volume:
$3.01 Open:
CNTB Latest News
March 10, 2026 09:00:00 am
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 03, 2026 09:00:00 am
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
February 19, 2026 09:00:00 am
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
January 12, 2026 08:00:00 am
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
CNTB Stock Data
$149,262,380
15,429,370
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
CN
San Diego
